Browse Category

Earnings Reports 5 November 2025

Palantir Stock (PLTR) on Nov. 5, 2025: Shares Slip Amid AI Sell‑Off Despite Blowout Q3, Higher Guidance and Fresh Price‑Target Hikes

Palantir Stock (PLTR) on Nov. 5, 2025: Shares Slip Amid AI Sell‑Off Despite Blowout Q3, Higher Guidance and Fresh Price‑Target Hikes

Palantir Technologies’ stock traded lower on Wednesday as investors extended a two‑day pullback in high‑flying AI names—even after Palantir’s blockbuster third‑quarter results, a higher full‑year outlook, and a wave of new analyst price‑target increases. A broad tech wobble that began Tuesday continued to weigh on sentiment, with Palantir singled out as an example of rich valuations meeting sky‑high expectations. Reuters
5 November 2025
···
Teradata’s 19% Stock Surge: AI Ambitions, Earnings Beat & What’s Next for TDC Investors

Teradata’s 19% Stock Surge: AI Ambitions, Earnings Beat & What’s Next for TDC Investors

As of November 5, 2025, Teradata’s stock trades in the mid-$20s after a sharp post-earnings rally. The latest trade was around $24.64, up ~19% in a single session Reuters. This big jump followed the company’s Q3 earnings announcement and reflects renewed investor confidence. Prior to the earnings, TDC was hovering near $20, meaning the stock has swiftly regained lost ground.
5 November 2025
···
SoFi Stock Soars 171% to Record Highs on Breakout Earnings – Will the Rally Continue? (Nov 2025 Update)

SoFi Stock Soars 171% to Record Highs on Breakout Earnings – Will the Rally Continue? (Nov 2025 Update)

SoFi Technologies’ stock has been on a tear in 2025, dramatically outperforming the broader market. As of November 5, 2025, SOFI trades around $29–30 per share, not far from its all-time high set just days earliertradingview.com. In late October, the stock spiked to an intraday record of $32.57247wallst.com, buoyed by optimism around its earnings. Even after pulling back about 7% from the peak in early November247wallst.com, SoFi shares are still up roughly 91% year-to-date and +171% versus a year agotradingview.com – a meteoric rise that has put the fintech firmly in the spotlight.
5 November 2025
··
Cipher Mining Stock Skyrockets on Blockbuster AWS Deal – Latest Earnings, Expert Insights & Price Forecast

Cipher Mining Stock Skyrockets on Blockbuster AWS Deal – Latest Earnings, Expert Insights & Price Forecast

Cipher Mining’s stock has been on a tear. In the final week of October into early November 2025, CIFR rocketed from the high teens to the mid-$20s per sharestockanalysis.comstockanalysis.com. On Monday, Nov 3, shares opened slightly down but closed up over 22% in a single session247wallst.com – an eye-popping move for a mid-cap stock. This surge was directly catalyzed by the company’s Q3 earnings release and strategic partnership news. By mid-day Nov 5, CIFR was trading around $25stockanalysis.com, marking roughly a 35% gain week-to-date and a new 52-week high for the stock.
5 November 2025
··
Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Outlook

Rigel Pharmaceuticals (RIGL) Stock Skyrockets on Earnings Beat – Latest Drug Updates & Analyst Outlook

Rigel’s stock has been on a tear in 2025, reflecting its improving fundamentals. As of November 5, 2025, RIGL trades around $38/share, up over 30% in a single day after its blowout Q3 earnings reportstockanalysis.com. The post-earnings volatility has been extreme – initially, shares fell ~7–8% in after-hours trading on Nov. 4 despite the strong results, possibly due to profit-taking or tempered forward outlook, dipping to about $30.32investing.com. However, sentiment swiftly reversed: by the next trading session, buyers piled in, and Rigel stock skyrocketed to new multi-month highs. The stock is now only a few points shy of its 52-week peak of $43.72investing.com.
5 November 2025
··
Lumentum Stock Skyrockets on AI Boom – Record Sales & Bold Forecast

Lumentum Stock Skyrockets on AI Boom – Record Sales & Bold Forecast

Lumentum made headlines on November 4–5, 2025 with a stellar earnings report that ignited its stock. The firm announced Q1 FY2026 results featuring record-high sales of $533.8 million – about 58% higher than a year agosimplywall.st and even slightly above Wall Street’s consensusmarketscreener.com. This top-line feat, the largest quarterly revenue in Lumentum’s 10-year historyoptics.org, was driven by unprecedented demand from AI and cloud networking customers. CEO Michael Hurlston highlighted that “over 60% of our total company revenue now comes from cloud and AI infrastructure” as hyperscalers deploy Lumentum’s optical components in data centersoptics.org. The AI-fueled sales boom helped Lumentum swing from a large loss last year to a modest profit this quarter – GAAP net income of $5M pre-tax, versus a nearly $80M loss in the year-ago periodoptics.org.
5 November 2025
··
Babcock & Wilcox (BW) Stock Skyrockets on AI Power Deal – Key Facts, Q3 Earnings & 2025 Outlook

Babcock & Wilcox (BW) Stock Skyrockets on AI Power Deal – Key Facts, Q3 Earnings & 2025 Outlook

Babcock & Wilcox Enterprises, Inc. is an American energy technology and services provider with a 158-year legacy. Headquartered in Akron, Ohio, the company is historically renowned for its steam boilers used in power generation Wikipedia. Today, B&W’s offerings span advanced energy and environmental solutions for industrial and utility markets worldwide Tipranks. It engineers and supplies equipment for power generation, emissions control systems, and related services/parts.
5 November 2025
·····
Trex Stock Plunges on Earnings Miss – What’s Next for the Decking Leader?

Trex Stock Plunges on Earnings Miss – What’s Next for the Decking Leader?

Trex stock has endured a steep slide in 2025, culminating in a dramatic plunge after its early November earnings announcement. On November 5, 2025, TREX opened around $34–35 per share – down roughly 26% from the prior day’s close Streetinsider. This selloff pushed the stock to fresh 52-week lows, shattering the previous low of ~$46 Finviz. Prior to the earnings drop, Trex had already been trending downward for months; with this latest collapse, shares have lost about 50% of their value year-to-date Finviz and over 50% from 12-month highs.
5 November 2025
···
Why Zeta Global (ZETA) Stock Is Soaring: 17 Straight Beats, AI Power, and Big Upside Ahead

Why Zeta Global (ZETA) Stock Is Soaring: 17 Straight Beats, AI Power, and Big Upside Ahead

Zeta Global made headlines on November 4, 2025 by reporting stellar third-quarter results and raising its guidance for the 17th straight quarterinvestors.zetaglobal.com. The Q3 earnings release showed better-than-expected revenue and profits, prompting a surge of optimism from investors and analysts alike. By the next day, ZETA’s stock price had soared roughly 15% in heavy trading as the market digested the newsstockanalysis.com. This marked a sharp positive turnaround, especially considering that just a few months prior the stock was languishing near yearly lows.
5 November 2025
···
DigitalOcean Stock Skyrockets on AI Momentum and Earnings Beat – What’s Next for DOCN?

DigitalOcean Stock Skyrockets on AI Momentum and Earnings Beat – What’s Next for DOCN?

DigitalOcean’s stock has seen dramatic near-term gains on the back of its latest earnings news. The shares closed at $39.11 on Nov. 4, 2025marketbeat.com, then soared roughly 15–17% in pre-market and early trading after the Q3 report to around the mid-$45 rangemarketbeat.com. This post-earnings rally stands out because the stock had been relatively flat in the month prior before optimism built ahead of the reportchartmill.com. On October 31, for example, DOCN jumped over 7% intraday to ~$41 on strong momentum and anticipationmarketsmojo.com.
5 November 2025
····
Pinterest Stock Plunges 18% on Earnings Miss – Can AI and Record Users Fuel a Rebound?

Pinterest Stock Plunges 18% on Earnings Miss – Can AI and Record Users Fuel a Rebound?

Pinterest stock tumbled after its latest earnings release, with shares sinking 18% on Nov. 5 as the company’s weak holiday-quarter outlook spooked investorsinvesting.com. The steep drop – the stock’s worst single-day slide in years – came despite strong user growth and solid revenue gains. Pinterest’s management forecast Q4 revenue of $1.31–1.34 billion, slightly below Wall Street’s ~$1.34B consensus at the midpoint, fueling fears of slowing momentuminvesting.com. This dour guidance, combined with an earnings miss, sparked a broad selloff.
5 November 2025
··
Super Micro’s AI Server Boom: SMCI Stock Stumbles on Earnings Miss but Preps for a Major Rebound

Super Micro’s AI Server Boom: SMCI Stock Stumbles on Earnings Miss but Preps for a Major Rebound

Super Micro’s latest earnings report initially shocked investors, sending the stock down over 8–9% in after-hours and pre-market trading Reuters Alphaspread. The company missed Wall Street’s expectations on both the top and bottom lines. Revenue for the September quarter came in at $5.0 billion, well under the ~$5.8–6.0B analysts had anticipated Finanznachrichten. This was a 15.5% drop from the $5.94B in the same quarter last year Finanznachrichten – a rare year-over-year decline for a high-growth tech company. Net income plunged accordingly; GAAP earnings were just $0.26 per share Finanznachrichten. On an adjusted basis, EPS was $0.35, missing consensus by roughly 10–25% Finanznachrichten Marketbeat.
5 November 2025
····
Teva Stock Soars on Earnings Beat: Inside Teva’s 2025 Comeback and What’s Next for Investors

Teva Stock Soars on Earnings Beat: Inside Teva’s 2025 Comeback and What’s Next for Investors

Teva’s financial turnaround appears to be gaining steam, driven by both top-line growth and disciplined cost management. Quarterly revenue has now grown year-over-year for 11 straight quartersinvesting.com, marking a sustained rebound after a difficult past decade. In Q3 2025, revenue rose ~3% YoY to $4.48 Binvesting.com, while adjusted earnings jumped to $0.78 per sharereuters.com. Notably, this beat Wall Street estimates by ~$0.10 and marked Teva’s strongest earnings surprise of 2025reuters.com. The growth engines are Teva’s newer branded drugs: movement-disorder treatment Austedo, migraine injection Ajovy, and schizophrenia depot UZEDY. Together these “innovative medicines” climbed 33% YoY and contributed $830 M this quarterinvesting.com, helping offset flat-to-declining sales in older generic categories. “Our key innovative brands…delivered a 33% increase…underscoring their impact on both patient outcomes and our financial performance,” CEO Richard Francis notedtevapharm.comtevapharm.com. Importantly, Austedo’s momentum led management to raise Austedo’s 2025 revenue outlook to $2.05–$2.15 Binvesting.com. This bodes well for continued earnings expansion, since these specialty products carry higher margins than commodity generics.
5 November 2025
···
Axon Enterprise (AXON) Stock Plunges on Earnings Miss – What’s Next for the Taser Maker?

Axon Enterprise (AXON) Stock Plunges on Earnings Miss – What’s Next for the Taser Maker?

Axon’s stock has experienced whiplash in early November. After closing at $706.13 on Nov 4stockanalysis.com, shares tumbled to around $563 in pre-market trading the next daystockanalysis.com. This ~20% drop followed the company’s Q3 earnings announcement, where profits disappointed Wall Street. In fact, Axon’s stock had already been sliding for several days heading into the report – falling four days in a row from about $732 at the end of October to $706 on Nov 4stockinvest.us.
5 November 2025
···
Humana (HUM) Stock on Nov 5, 2025: Earnings Beat, Outlook Trimmed – Full Analysis

Humana (HUM) Stock on Nov 5, 2025: Earnings Beat, Outlook Trimmed – Full Analysis

In summary, Humana Inc. faces a pivotal moment: it’s balancing short-term earnings headwinds from elevated costs and rating setbacks against strong long-term fundamentals in the Medicare Advantage space. The latest news provides some relief that management’s corrective actions are workingreuters.comreuters.com. However, caution prevails as 2026 looms without guidance and with likely flat profitsreuters.com. Investors should watch upcoming quarters for signs of cost trend stabilization, membership retention during open enrollment, and progress on quality metrics. Humana’s ability to navigate these challenges under new leadership will determine if the stock can regain its former strength. For now, the consensus is that Humana will weather the storm: it remains a market leader in a growing sector, with a strategy to adapt and thrive. As one analyst succinctly put it, “Humana’s crown slipped, but it’s far from lost.” The coming year will show how quickly that crown can be polished again.
5 November 2025
··
Lemonade (LMND) Stock Soars on Q3 Beat – Is Insurtech Growth Sustainable?

Lemonade (LMND) Stock Soars on Q3 Beat – Is Insurtech Growth Sustainable?

On Nov. 5, 2025 after market-close, Lemonade released its Q3 financials, and the stock surged. Both press coverage and company statements highlighted robust top-line growth and improving loss metrics. For example, Investing.com reported revenue +42% YOY to $194.5M and a narrower-than-forecast loss of $0.51 per shareau.investing.com. It noted in-force premium up 30% YOY to $1.16B – an eighth consecutive quarter of accelerating growthau.investing.com. The CEO, Daniel Schreiber, said: “In Q3, we continued both our growth acceleration — crossing 30% IFP growth ahead of schedule — and our steady progress toward profitability.”investorshub.advfn.com.
5 November 2025
··
1 … 255 256 257 258 259 … 270
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY ON PULLBACK

Microsoft

NASDAQ: MSFT 94 / 100
#2 BUY

L3Harris Technologies

NYSE: LHX 90 / 100
#3 BUY

Xylem

NYSE: XYL 89 / 100
#4 BUY IN TRANCHES

Lam Research

NASDAQ: LRCX 87 / 100
#5 BUY ON WEAKNESS

GE HealthCare

NASDAQ: GEHC 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.